ROKA - Sorrento Tech, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

Sorrento Tech, Inc.

20 Independence Boulevard
Warren, NJ 07059
United States

IndustryMedical Laboratories & Research
Full Time Employees90

Key Executives

Mr. Paul G. ThomasFounder and Chairman613.62kN/A61
Ms. Mary Beth DuseauChief Exec. Officer, Pres, Sec. and Director481.69kN/A52
Mr. Lars BoesgaardChief Financial Officer, VP and Treasurer312.23kN/A47
Dr. Michael BeckerChief Scientific OfficerN/AN/AN/A
Mr. Kevin GirouxVP of Sales and MarketingN/AN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Roka Bioscience, Inc., a molecular diagnostics company, focuses on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens in the United States. It provides Atlas instrument, a fully automated molecular diagnostic testing instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single and integrated platform. The company also offers atlas detection assays that include molecular tests for Salmonella, Listeria, E. coli O157:H7, Shiga toxin- producing E.coli, and Listeria monocytogenes, as well as related consumable supplies. It serves food processors, third-party contract testing laboratories, and government regulatory authorities. The company was founded in 2009 and is headquartered in Warren, New Jersey.

Corporate Governance

Sorrento Tech, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.